Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

Yvan Martineau

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0575-4085; OpenAlex author ID A5085409864. Sources: OpenAlex.

Their work

Papers
9 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
29
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 9

  1. Decoding the Integrated Stress Response of Pancreatic Cancer: Identifying a Serine-dependent Tumor Subset Under Metabolic Relationships With CAFs. Last author DOI 10.1002/advs.202515740↗
  2. Molecular subtypes in pancreatic cancer: from academic promise to clinical reality. Co-author DOI 10.1186/s12943-026-02614-9↗
  3. Mass Spectrometry-Based Workflow for the Identification and Quantification of Alternative and Canonical Proteins in Pancreatic Cancer Cells. Co-author DOI 10.3390/cells13231966↗
  4. Translational alterations in pancreatic cancer: a central role for the integrated stress response. Last author DOI 10.1093/narcan/zcac031↗
  5. Pharmacologic Normalization of Pancreatic Cancer-Associated Fibroblast Secretome Impairs Prometastatic Cross-Talk With Macrophages. Co-author DOI 10.1016/j.jcmgh.2021.01.008↗
  6. Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer Last author DOI 10.1016/j.pan.2021.05.117↗
  7. FAK activity in cancer-associated fibroblasts is a prognostic marker and a druggable key metastatic player in pancreatic cancer. Co-author DOI 10.15252/emmm.202012010↗
  8. eIF4A inhibition circumvents uncontrolled DNA replication mediated by 4E-BP1 loss in pancreatic cancer. Last author DOI 10.1172/jci.insight.121951↗
  9. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts. Co-author DOI 10.18632/oncotarget.9296↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Corinne Bousquet · 7 shared papers, 2016–2026 · strength 0.81
  2. Stéphane Pyronnet · 7 shared papers, 2016–2026 · strength 0.81
  3. Christine Jean · 6 shared papers, 2016–2026 · strength 0.62
  4. Sauyeun Shin · 4 shared papers, 2019–2026 · strength 0.58
  5. Cindy Neuzillet · 4 shared papers, 2020–2026 · strength 0.49
  6. Rémi Samain · 5 shared papers, 2016–2021 · strength 0.41
  7. Rémy Nicolle · 3 shared papers, 2021–2026 · strength 0.41
  8. Elisa Espinet · 1 shared paper, 2026 · strength 0.36
  9. Daniela M. D'Empaire Altimari · 1 shared paper, 2026 · strength 0.36
  10. Elisa Giovannetti · 1 shared paper, 2026 · strength 0.36
  11. Victor Javier Sanchez-Arevalo Lobo · 1 shared paper, 2026 · strength 0.36
  12. Juan Iovanna · 2 shared papers, 2021–2026 · strength 0.32
  13. Nelson Dusetti · 2 shared papers, 2021–2026 · strength 0.32
  14. Nicolas Alejandro Fraunhoffer · 1 shared paper, 2026 · strength 0.21
  15. Jérôme Raffenne · 2 shared papers, 2021 · strength 0.20
  16. Bertrand Fabre · 1 shared paper, 2024 · strength 0.18
  17. Clémence Guillon · 1 shared paper, 2024 · strength 0.18
  18. Jerome F. Cros · 2 shared papers, 2020–2021 · strength 0.18
  19. Richard Tomasini · 2 shared papers, 2020–2021 · strength 0.18
  20. Emilie Decaup · 2 shared papers, 2016–2020 · strength 0.14
  21. Matteo Ponzo · 1 shared paper, 2021 · strength 0.09
  22. Jérémy Nigri · 1 shared paper, 2021 · strength 0.09
  23. Ilaria Cascone · 1 shared paper, 2021 · strength 0.09
  24. Sonia Zaghdoudi · 1 shared paper, 2020 · strength 0.08
  25. Oliver M.T. Pearce · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.